• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Effects of Dexamethasone on Post-Operative Urinary Retention in Laparoscopic Inguinal Hernia Repair

Effects of Dexamethasone on Post-Operative Urinary Retention in Laparoscopic Inguinal Hernia Repair

Merritt Denham, BS, Kara Donovan, BS, Nicole Wetoska, Kristine Kuchta, MS, JoAnn Carbray, BS, John G Linn, MD, Woody Denham, MD, Stephen P Haggerty, MD, FACS, Michael Ujiki, MD, FACS. NorthShore University Health System

Introduction: Post-operative urinary retention (POUR) is a complication of Laparoscopic Inguinal Hernia Repair (LIHR). Previous research has examined predictive perioperative factors of POUR, with several studies pointing to age and presence of benign prostatic hyperplasia (BPH) as significant factors. But there is currently limited work on preventative measures for POUR. We hypothesize that dexamethasone, a steroid, reduces the rate of urinary retention following LIHR due to its mechanism.

Methods: Consecutive patients (n=955) undergoing LIHR from 2009-2017 at a single institution were selected from a prospectively managed database. All procedures were performed by four general surgeons. Only male patients were selected, as the vast majority of urinary retention complications occur in males. These patients were retroactively chart reviewed and divided into two groups, dexamethasone use (n=617) and no dexamethasone use (n=338). Perioperative factors were compared between groups with chi-square and independent samples t-tests. Univariable and multivariable logistic regression analysis was used to assess whether dexamethasone use was associated with POUR. A subgroup analysis was performed on the dexamethasone group, to determine if there was a dose-dependent effect.

Results: Our study showed a significant difference in POUR between the dexamethasone group and no dexamethasone group (3.7% vs. 9.8%, p=.0001). Patients in the dexamethasone group had a shorter length of stay, and were less likely to have BPH or a foley placed (all p<.05). Age and BMI were similar between groups. Multivariable analysis showed the use of dexamethasone was associated with a reduced risk of POUR (OR=0.52, 95% CI: 0.2-0.97, p=0.0386), while controlling for other factors such as age and presence of BPH. A subgroup analysis examined the effect of dexamethasone per unit (mg) increase. There was no significant association between dexamethasone dose and POUR rates (OR=1.07, 95% CI 0.82-1.38, p=0.6241).

Discussion: In this retrospective review of 955 patients, those who received dexamethasone showed a significantly lower rate of POUR regardless of dose. These results suggest that dexamethasone can be administered to reduce POUR in males undergoing laparoscopic inguinal hernia repair.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 88428

Program Number: S006

Presentation Session: Hernia Session

Presentation Type: Podium

166

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals